UMPS antibody (C-Term)
Quick Overview for UMPS antibody (C-Term) (ABIN631243)
Target
See all UMPS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- UMPS antibody was raised against the C terminal of UMPS
-
Purification
- Affinity purified
-
Immunogen
- UMPS antibody was raised using the C terminal of UMPS corresponding to a region with amino acids VGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDII
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
UMPS Blocking Peptide, (ABIN5616907), is also available for use as a blocking control in assays to test for specificity of this UMPS antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of UMPS antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UMPS (Uridine Monophosphate Synthetase (UMPS))
-
Alternative Name
- UMPS
-
Background
- OPRT (UMPS) is involved in early events of pancreatic and gallbladder carcinogenesis and invasion of hepatocellular carcinomas. Orotate phosphoribosyltransferase is involved in the invasion and metastasis of colorectal carcinoma. Determination of OPRT levels in gastric carcinoma tissue enables to predict the response to S-1-based neoadjuvant/adjuvant chemotherapy.
-
Molecular Weight
- 52 kDa (MW of target protein)
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-